We are live on
!
Find out more
DCP
DSM Capital Partners Portfolio holdings
AUM
$5.66B
1-Year Est. Return
27.45%
This Fund
S&P 500
This Quarter
Est. Return
-0.84%
1 Year Est. Return
+27.45%
3 Year Est. Return
+126.04%
5 Year Est. Return
+156.94%
10 Year Est. Return
+722.36%
AUM
$4.79B
AUM Growth
-$201M
(-4%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-3.63%
Top 10 Holdings %
Top 10 Hldgs %
47.04%
Holding
89
New
9
Increased
38
Reduced
27
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$178M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$60.9M |
| 3 |
Cognizant
CTSH
|
+$47.6M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$37M |
| 5 |
CELG
Celgene Corp
CELG
|
+$27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$137M |
| 2 |
Biogen
BIIB
|
+$95.5M |
| 3 |
PX
Praxair Inc
PX
|
+$79.3M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$45.3M |
| 5 |
eBay
EBAY
|
+$44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 23% |
| 2 | Healthcare | 19.68% |
| 3 | Communication Services | 13.2% |
| 4 | Financials | 13.05% |
| 5 | Materials | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $364M | 7.6% |
5,215,200
+341,016
| +7% | +$27M |
|
|
2
Alphabet (Google) Class C
GOOG
$4.29T
| $262M | 5.47% |
9,435,595
+2,091,651
| +28% | +$60.9M |
|
|
MON
3
DELISTED
Monsanto Co
MON
| $259M | 5.4% |
2,275,715
+7,668
| +0.3% | +$854K |
|
4
Booking.com
BKNG
$139B
| $236M | 4.94% |
4,959,075
+84,125
| +2% | +$4.15M |
|
|
TWX
5
DELISTED
Time Warner Inc
TWX
| $225M | 4.69% |
3,587,139
+36,288
| +1% | +$2.28M |
|
|
6
Cognizant
CTSH
$21.1B
| $203M | 4.23% |
4,004,878
+952,896
| +31% | +$47.6M |
|
7
Yum! Brands
YUM
$40.6B
| $179M | 3.74% |
3,304,437
+423,832
| +15% | +$22.3M |
|
|
8
Starbucks
SBUX
$119B
| $176M | 3.68% |
+4,809,156
| New | +$178M |
|
9
Blackrock
BLK
$163B
| $171M | 3.57% |
544,001
-15,777
| -3% | -$4.82M |
|
10
Dollar General
DG
$27.5B
| $167M | 3.49% |
3,010,116
+82,082
| +3% | +$4.78M |
|
11
Visa
V
$686B
| $163M | 3.41% |
3,024,868
-131,780
| -4% | -$7.32M |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals
ALXN
| $156M | 3.26% |
1,027,161
-284,827
| -22% | -$45.3M |
|
13
Wynn Resorts
WYNN
$9.93B
| $155M | 3.24% |
698,527
-179,369
| -20% | -$39.5M |
|
14
Intuitive Surgical
ISRG
$125B
| $146M | 3.05% |
3,002,994
+171,054
| +6% | +$8.06M |
|
|
15
Regeneron Pharmaceuticals
REGN
$70.5B
| $145M | 3.03% |
483,267
+120,154
| +33% | +$37M |
|
16
Warner Bros
WBD
$64.8B
| $135M | 2.81% |
3,186,992
-448,957
| -12% | -$18.9M |
|
17
Mastercard
MA
$484B
| $134M | 2.79% |
1,791,865
-58,685
| -3% | -$4.58M |
|
|
18
eBay
EBAY
$50.7B
| $133M | 2.78% |
5,731,820
-1,895,727
| -25% | -$44M |
|
19
Invesco
IVZ
$13.1B
| $133M | 2.78% |
3,598,476
+276,828
| +8% | +$9.59M |
|
|
20
Biogen
BIIB
$29.5B
| $128M | 2.68% |
419,674
-300,747
| -42% | -$95.5M |
|
21
Las Vegas Sands
LVS
$30.4B
| $120M | 2.49% |
1,479,341
-528,897
| -26% | -$42.5M |
|
22
Monster Beverage
MNST
$93.4B
| $118M | 2.46% |
10,186,230
-1,113,606
| -10% | -$13M |
|
|
PCP
23
DELISTED
PRECISION CASTPARTS CORP
PCP
| $95.8M | 2% |
378,900
-48,467
| -11% | -$12.5M |
|
24
TJX Companies
TJX
$172B
| $91.7M | 1.91% |
3,024,190
+121,196
| +4% | +$3.67M |
|
25
Ecolab
ECL
$75.6B
| $78.1M | 1.63% |
722,823
-210,255
| -23% | -$22M |
|
Similar funds
F
RMDI
AIM
O
AC
CRC
QP
ACM
DSM Capital Partners's Q1 2014 Portfolio in Review
As of Q1 2014, DSM Capital Partners held 89 positions worth $4.79B, down 4% from $4.99B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
DSM Capital Partners withdrew a net $174M in Q1 2014, closing 15 positions and reducing 27 holdings. Its most notable exit was Estee Lauder, an estimated $137M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, DSM Capital Partners opened a new position in Starbucks worth $176M.
- DSM Capital Partners's largest Q1 2014 buy was Starbucks: 4,809,156 shares worth $176M.
- DSM Capital Partners added most to Alphabet (Google) Class C in Q1 2014, an estimated $60.9M increase.
- DSM Capital Partners's biggest Q1 2014 reduction was Biogen, cutting an estimated $95.5M.
- DSM Capital Partners fully exited Estee Lauder in Q1 2014, selling an estimated $137M.
- DSM Capital Partners's ten largest holdings make up 47% of its $4.79B portfolio in Q1 2014.
- DSM Capital Partners opened 9 new positions and closed 15 in Q1 2014.
- DSM Capital Partners's portfolio value fell 4% quarter-over-quarter to $4.79B.
Based on DSM Capital Partners's 13F filing for Q1 2014, filed 13 May 2014.